A polypeptide derived from gp41, a vaccine composition...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/385 (2006.01) A61P 31/18 (2006.01) A61P 37/04 (2006.01) C07K 16/10 (2006.01) G01N 33/564 (2006.01) A61K 39/21 (2006.01) C07K 14/16 (2006.01)

Patent

CA 2558733

The present invention relates to the field of the in vitro diagnosis of the progression status of an infection of an individual with a virus belonging to the family of the Human Immunodeficiency Viruses (HIV) as well as with the therapeutical treatment of this infectious disease. The invention also relates to immunological compounds and vaccine compositions comprising a polypeptide derived from gp41.

La présente invention concerne le domaine du diagnostic in vitro de l'état de progression d'une infection chez une personne atteinte d'un virus appartenant à la famille des virus de l'immunodéficience humaine (VIH) ainsi que le traitement thérapeutique de cette maladie infectieuse. Cette invention concerne aussi des composés immunologiques et des compositions de vaccin comprenant un polypeptide dérivé de gp41.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A polypeptide derived from gp41, a vaccine composition... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A polypeptide derived from gp41, a vaccine composition..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A polypeptide derived from gp41, a vaccine composition... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1481504

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.